Latest Market Positioning News

Peninsula Energy has locked in a $15 million debt facility from Davidson Kempner to advance commissioning at its Lance uranium project and support an upcoming equity raise. The funding aims to sustain momentum towards production resumption and ASX relisting.

Imricor Medical Systems has secured key European regulatory approvals for its second-generation NorthStar system and initiated its commercial launch, while US FDA submissions progress amid some delays.

Change Financial has surpassed its FY25 revenue targets and is set to report its first positive underlying EBITDA, signaling a pivotal shift for the fintech. The company also projects strong revenue and earnings growth for FY26, underpinned by robust sales momentum and operational efficiencies.

ClearVue Technologies and LandGlass subsidiary LandVac have entered a strategic partnership to co-develop and commercialize advanced solar vacuum insulated glazing products, aiming to revolutionize energy-efficient building materials worldwide.

Viridis Mining and Minerals has released a comprehensive Pre-Feasibility Study for its Colossus Rare Earth Project in Brazil, showcasing robust economics, low-cost production, and a clear path to production by 2028. The study highlights the project's resilience across price cycles and its strategic positioning in the global rare earth supply chain.

GQG Partners reported a record US$172.4 billion in funds under management as of June 30, 2025, despite relative underperformance due to a defensive portfolio stance. Net inflows remain solid but show signs of moderation compared to last year.

Nanoveu’s subsidiary EMASS has reached a key milestone by moving its ECS-DoT AIoT chip into 16nm synthesis, while unveiling a Modular AIoT Development Kit to accelerate edge intelligence adoption.

West African Resources has achieved its first gold pour at the Kiaka project while maintaining solid production at Sanbrado, positioning the company well to meet its 2025 targets.

ARC Funds Limited has voluntarily suspended trading on the ASX pending a crucial announcement about its proposed capital raising, signaling a pivotal moment for the investment fund.

Resonance Health is expanding its clinical trial operations with a third TrialsWest site in Mandurah, WA, set to open in August 2025, enhancing participant recruitment and supporting ongoing pharmaceutical trials.

Hydralyte USA has placed 39.5 million shortfall shares at $0.01 each, boosting total funds raised under its recent Rights Issue to nearly $559,000. The move strengthens the company’s capital position amid ongoing growth efforts.

L1 Capital and Platinum Asset Management have formalised their merger with a binding agreement, promising continuity for L1 Long Short Fund's management and strategy.